1. Home
  2. RIGL vs CMP Comparison

RIGL vs CMP Comparison

Compare RIGL & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigel Pharmaceuticals Inc.

RIGL

Rigel Pharmaceuticals Inc.

N/A

Current Price

$39.76

Market Cap

911.8M

Sector

Health Care

ML Signal

N/A

Logo Compass Minerals Intl Inc

CMP

Compass Minerals Intl Inc

N/A

Current Price

$19.64

Market Cap

999.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
RIGL
CMP
Founded
1996
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
911.8M
999.1M
IPO Year
2000
2003

Fundamental Metrics

Financial Performance
Metric
RIGL
CMP
Price
$39.76
$19.64
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
★ $64.40
$29.50
AVG Volume (30 Days)
204.0K
★ 342.1K
Earning Date
11-05-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1867.68
N/A
EPS
★ 1.97
0.59
Revenue
★ $294,282,000.00
N/A
Revenue This Year
$5.32
$3.43
Revenue Next Year
$24.14
$3.07
P/E Ratio
★ $21.00
$33.95
Revenue Growth
★ 64.15
N/A
52 Week Low
$24.84
$16.77
52 Week High
$52.61
$34.50

Technical Indicators

Market Signals
Indicator
RIGL
CMP
Relative Strength Index (RSI) 34.58 26.12
Support Level $37.60 N/A
Resistance Level $43.74 $23.58
Average True Range (ATR) 2.72 0.68
MACD -0.62 -0.34
Stochastic Oscillator 15.98 4.33

Price Performance

Historical Comparison
RIGL
CMP

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: